View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Deals Analysis
November 8, 2021

Medical Devices industry big data deals total $1bn globally in Q3 2021

Avidity Partners, BlackRock, Pura Vida Investments, RA Capital Management and Sands Capital Management’s $220m venture financing deal with eXo Imaging was the medical devices industry’s biggest big data deal of Q3 2021 as big data deals worth $1bn were announced globally in the quarter, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked an increase of 50.2% over the previous quarter and a drop of 66.9% when compared with the last four-quarter average of $3.08bn.

In terms of number of big data deals, the sector saw a drop of 16.52% with 24 deals in Q3 2021 against the average of 28.75 deals in the last four-quarters.

In value terms, Asia-Pacific led the activity with big data deals worth $404.24m.

medical devices industry big data deals in Q3 2021: Top deals

The top five medical devices industry big data deals accounted for 74.2% of the overall value during Q3 2021.

The combined value of the top five big data deals stood at $759.1m, against the overall value of $1bn recorded for the quarter.

The top five medical devices industry big data deals of Q3 2021 tracked by GlobalData were:

1) Avidity Partners,BlackRock,Pura Vida Investments,RA Capital Management and Sands Capital Management $220m venture financing deal with eXo Imaging

2) The $200m acquisition of Zebra Medical Vision by Nano-X Imaging

3) CCB Trust,Chinese Fund of Funds (FOF),Goldman Sachs Asset Management,Springhill Fund,TopoScend Capital and Zhongguancun M&A Fund $139.1m venture financing deal with Beijing Infervision Technology

4) The $100m venture financing of Pulse Medical Imaging Technology (Shanghai) by Boyu Capital Consultancy,GL Ventures,Goldman Sachs Group,Insight Capital,Koninklijke Philips and Linden Asset Management

5) Hibercell $100m acquisition deal with Genuity Science

Related Companies

Verdict deals analysis methodology

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network